These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7857714)

  • 1. Aldehyde dehydrogenase involvement in a variant of the brown Norway rat acute myelocytic leukaemia (BNML) that acquired cyclophosphamide resistance in vivo.
    de Groot CJ; Martens AC; Hagenbeek A
    Eur J Cancer; 1994; 30A(14):2137-43. PubMed ID: 7857714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterisation of a cyclophosphamide resistant variant of the BNML rat model for acute myelocytic leukaemia.
    Martens AC; de Groot CJ; Hagenbeek A
    Eur J Cancer; 1991; 27(2):161-6. PubMed ID: 1827281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo development of an acetyldinaline resistant subline of the BN rat acute myelocytic leukemia (BNML).
    el-Beltagi HM; Martens AC; Haroun EA; Hagenbeek A
    Leukemia; 1993 Aug; 7(8):1275-80. PubMed ID: 8350629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of a cyclophosphamide-resistant subline of acute myeloid leukemia in the Lewis x Brown Norway hybrid rat.
    Koelling TM; Yeager AM; Hilton J; Haynie DT; Wiley JM
    Blood; 1990 Sep; 76(6):1209-13. PubMed ID: 2400809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic cellular resistance to oxazaphosphorines exhibited by a human colon carcinoma cell line expressing relatively large amounts of a class-3 aldehyde dehydrogenase.
    Rekha GK; Sreerama L; Sladek NE
    Biochem Pharmacol; 1994 Nov; 48(10):1943-52. PubMed ID: 7986206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxazaphosphorine-specific resistance in human MCF-7 breast carcinoma cell lines expressing transfected rat class 3 aldehyde dehydrogenase.
    Bunting KD; Lindahl R; Townsend AJ
    J Biol Chem; 1994 Sep; 269(37):23197-203. PubMed ID: 8083225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines.
    Kohn FR; Landkamer GJ; Manthey CL; Ramsay NK; Sladek NE
    Cancer Res; 1987 Jun; 47(12):3180-5. PubMed ID: 3034402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose cyclophosphamide treatment of acute myelocytic leukemia. Studies in the BNML rat model.
    Hagenbeek A; Martens AC
    Eur J Cancer Clin Oncol; 1982 Aug; 18(8):763-9. PubMed ID: 6759141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of acetyldinaline for treatment of minimal residual disease (MRD): preclinical studies in the BNML rat model for human acute myelocytic leukemia.
    el-Beltagi HM; Martens AC; Dahab GM; Hagenbeek A
    Leukemia; 1993 Nov; 7(11):1795-800. PubMed ID: 8231248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bivariate flow karyotyping of acute myelocytic leukemia in the BNML rat model.
    Arkesteijn GJ; Martens AC; Jonker RR; Hagemeijer A; Hagenbeek A
    Cytometry; 1987 Nov; 8(6):618-24. PubMed ID: 3480794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines.
    Sladek NE; Landkamer GJ
    Cancer Res; 1985 Apr; 45(4):1549-55. PubMed ID: 3978623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro resistance of the brown Norway rat acute myelocytic leukemia (BNML) to lymphokine-activated killer activity.
    Gaiser JF; Kloosterman TC; Martens AC; Hagenbeek A
    Leukemia; 1993 May; 7(5):736-41. PubMed ID: 8483327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BN acute myelocytic leukemia (BNML) (a rat model for studying human acute myelocytic leukemia (AML)).
    Martens AC; Van Bekkum DW; Hagenbeek A
    Leukemia; 1990 Apr; 4(4):241-57. PubMed ID: 2195239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human breast adenocarcinoma MCF-7/0 cells electroporated with cytosolic class 3 aldehyde dehydrogenases obtained from tumor cells and a normal tissue exhibit differential sensitivity to mafosfamide.
    Sreerama L; Sladek NE
    Drug Metab Dispos; 1995 Oct; 23(10):1080-4. PubMed ID: 8654195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of murine late spleen colony-forming cells (day-12 CFU-S) and hematopoietic repopulating cells to mafosfamide (ASTA Z 7557).
    Kohn FR; Sladek NE
    Biochem Pharmacol; 1987 Sep; 36(17):2805-11. PubMed ID: 2820422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amifostine (WR2721) for dose escalation in marrow-ablative treatment of leukaemia.
    Martens AC; Hagenbeek A
    Eur J Cancer; 1999 Apr; 35(4):634-40. PubMed ID: 10492639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate-specific deoxycytidine kinase deficiency in 1-beta-D-arabinofuranosylcytosine-resistant leukemic cells.
    Richel DJ; Colly LP; Arkesteijn GJ; Arentsen-Honders MW; Kerster MG; ter Riet PM; Willemze R
    Cancer Res; 1990 Oct; 50(20):6515-9. PubMed ID: 2208110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute myelocytic leukemia with interleukin-6 Pseudomonas exotoxin fusion protein in a rat leukemia model.
    Rozemuller H; Rombouts WJ; Touw IP; FitzGerald DJ; Kreitman RJ; Pastan I; Hagenbeek A; Martens AC
    Leukemia; 1996 Nov; 10(11):1796-803. PubMed ID: 8892684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfiram metabolism as a requirement for the inhibition of rat liver mitochondrial low Km aldehyde dehydrogenase.
    Yourick JJ; Faiman MD
    Biochem Pharmacol; 1991 Sep; 42(7):1361-6. PubMed ID: 1656985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dinaline: a new oral drug against leukemia? Preclinical studies in a relevant rat model for human acute myelocytic leukemia (BNML).
    Hagenbeek A; Weiershausen U; Martens AC
    Leukemia; 1988 Apr; 2(4):226-30. PubMed ID: 3163079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.